| Literature DB >> 27793846 |
Su Yeon Han1, Aram Ko1, Haruhisa Kitano2,3, Chel Hun Choi2,4, Min-Sik Lee1, Jinho Seo1, Junya Fukuoka5, Soo-Youl Kim6, Stephen M Hewitt2, Joon-Yong Chung2, Jaewhan Song7.
Abstract
The tumor suppressor function of p14ARF is regulated at a posttranslational level via mechanisms yet to be fully understood. Here, we report the identification of an unconventional p14ARF degradation pathway induced by the chaperone HSP90 in association with the E3 ubiquitin ligase C-terminus of HSP70-interacting protein (CHIP). The ternary complex of HSP90, CHIP, and p14ARF was required to induce the lysosomal degradation of p14ARF by an ubiquitination-independent but LAMP2A-dependent mechanism. Depletion of HSP90 or CHIP induced p14ARF-dependent senescence in human fibroblasts. Premature senescence observed in cells genetically deficient in CHIP was rescued in cells that were doubly deficient in CHIP and p14ARF. Notably, non-small cell lung cancer cells (NSCLC) positive for p14ARF were sensitive to treatment with the HSP90 inhibitor geldanamycin. Furthermore, overexpression of HSP90 and CHIP with a concomitant loss of p14ARF correlated with poor prognosis in patients with NSCLC. Our findings identify a relationship between p14ARF and its chaperones that suggest new therapeutic strategies in cancers that overexpress HSP90. Cancer Res; 77(2); 343-54. ©2016 AACR. ©2016 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27793846 PMCID: PMC8170830 DOI: 10.1158/0008-5472.CAN-16-0613
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701